VLDLR and obesity disorder: In addition, as shown in Figure 4D, NK significantly reduced the levels of serum triglyceride, causing us to question whether NK inhibits adipogenesis via the VLDL‐VLDLR signalling pathway in the HFD‐induced obesity mouse model.